Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access

SILVER SPRING, Md., Nov. 8, 2017 -- (Healthcare Sales & Marketing Network) -- To manage the risks associated with drugs, the FDA employs a range of tools. For drugs that are associated with serious risks, the FDA can require drug makers to develop a Risk E... Biopharmaceuticals, Generics, FDA U.S. Food and Drug Administration
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news